Abstract:Background and purpose: Gene transfer with recombinant non-viral vectors encoding vasodilator proteins, Such as endothelial nitric oxide synthase (eNOS), may be a preferential choice in gene therapy of artery restenosis following angioplasty, stent or anastomosis. However, the transfection rate of a non-viral vector, the harmful effects of eNOS transfection on endothelial cells (EC)and the control release of nitric oxide (NO) have been controversial. We designed the eukaryotic expression vector pcDNA3.1-eNOS to study the regulated expression of eNOS (in the presence of various chemical agents) and to evaluate the exogenous NO effect on EC proliferation in vitro.Methods: The full-length human eNOS cDNA was inserted into the EcoRI cloning site of the pcDNA3.1 expression plasmid and the eNOS direction was tested by restriction enzyme digestion with XhoI to construct recombinant pcDNA3.1-eNOS. After co-transfection of pcDNA3.1-eNOS with pcDNA3.0-EGFP mediated by cationic liposomes into Human umbilical vein endothelial cells (ECV304), the transfection rate and the effect on ECV304 proliferation were calculated by fluorescence microscopy and flowcytometry. eNOS mRNA and protein were detected by reverse transcription-PCR (RT-PCR) and immunofluorescence, respectively. The eNOS activity, NO release and changes of the relevant cells growth curve were assessed after treating the transfected cells with four independent factors including ie Ca2+, L-arginine (L-Arg), Ethylene Diamine Tetraacetic Acid (EDTA) and N-nitro-L-arginine methylester (L-NAME). In addition, we examined the nontransfected cells status by isolated sodium nitroprusside (SNP) treatment.Result: eNOS cDNA was inserted into pcDNA3.1 in die proper direction. RT-PCR analysis showed that pcDNA3.1-eNOS transfected cells could express eNOS mRNA. The rate of eNOS transfection was 39.6 +/- 3.4%. Immunofluorescence staining displayed that subcellular localisation of eNOS was most prominent in plasma membrane and per] nuclear regions of the cell. The eNOS activity of eNOS transfected cells had not increased significantly, whereas, in the presence of Call, L-Arg, EDTA, and L-NAME, the eNOS activity was 96.98 +/- 13.47, 32.57 +/- 6.39, 11.63 +/- 3.02, 15.56 +/- 7.34 U/ml respectively and the NO level was 55.34 +/- 11.19, 9.43 +/- 4.51., 2.63 +/- 1.41, 3.73 +/- 1.65 mmol/L, respectively. Meanwhile, die growth curves of EC shifted. SNP also had obvious growth-inhibiting effects on the cells. Together, the ECV304 growth curve went downward in a NO concentration-dependent manner.Conclusion: Eukaryotic expression vector pcDNA3.1-eNOS was constructed successfully with the ability to express human eNOS mRNA and protein in EC effectively. The activity of eNOS in EC could be regulated by certain exogenous factors. Ca2+ was an important factor promoting NO release and excess NO had a cytotoxic effect on EC in vitro. Controlled release of NO in vivo and polygenic measurements might be considered in more clinical gene therapy studies.

[Effect of Cobaltous Chloride on the Transcription Activity of Modified Human Enos Promoter].

Effect of Cobaltous Chloride on the Transcription Activity of Human Enos Promoter

Effects of Hypoxia on Levels of Nitric Oxide, Endothelin- 1 and Inducible Nitric Oxide Synthase Mrna Expression in Cultured Human Umbilical Vein Endothelial Cells

Sp1 Modification of Human Endothelial Nitric Oxide Synthase Promoter Increases the Hypoxia-Stimulated Activity.

Regulation of Human Endothelial Nitric Oxide Synthase (enos) Promoter Activity by P38α-Mitogen Activated Protein Kinase

Haplotype-Specific Effects on Endothelial NO Synthase Promoter Efficiency

[Effect of Total Panax Notoginseng Saponins on the Activity of Human Endothelial Nitric Oxide Synthase Gene Promoter].

Experimental Study of Recombinant Aukaryotic Expression Vector of Human Enos in ECV304 Cells

Endothelial nitric oxide synthase expression in endothelial cells following aukaryotic expression vector construction

Construction and Expression of Red Fluorescent Protein Vectors Containing Different Regions of Human Enos Promoter

Methods Polymerase Chain Reaction ( PCR ) Cloning of the eNOS Promoter and Intron 4 Into the pGL 3 Luciferase Reporter

Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of Sp1 activity

Cloning of SOD2 Promoter and Identification of Its Transcriptional Activity

Copper Is Required For Cobalt-Induced Transcriptional Activity Of Hypoxia-Inducible Factor-1

[Effect of Hypoxia on HIF-1α and Its Sumoylation in Jurkat Cells].

Effect of Nuclear Actin on Endothelial Nitric Oxide Synthase Expression

The Effects of CoCl2 on HIF-1α Protein under Experimental Conditions of Autoprogressive Hypoxia Using Mouse Models

Effects of Buyang Huanwu Decoction on the Promotor Activity of Endothelial Nitric Oxide Synthase Promotor

Construction and expression of red fluorescent protein reporter gene vector containing human eNOS promoter]

Genotype-Dependent Expression Of Endothelial Nitric Oxide Synthase (Enos) And Its Regulatory Proteins In Cultured Endothelial Cells

Cloning of HRE/CMV Promoters and Determination of Hypoxia Regulatory Activities